Boost your SEO with Backlinks that are worth it

Turn scattered startup information into focused action.

Submit your startup to 120+ top directories.

Edit

Upgrade

MAP Pharmaceuticals

MAP Pharmaceuticals is focused on developing novel inhalation therapies for respiratory and systemic diseases.

Acquired by Allergan on January 22, 2013

Website: https://www.mappharma.com

Founded: January 01, 2003

Social:

Add Competitor

Startup	Industry	Description
24Genetics	Pharmaceuticals & Biotechnology	DNA Testing for Ancestry and wellness - 24Genetics is a European Biotechnology startup tha ...
Vivodyne	Healthcare Equipment & Services	Discovers life-changing drugs and cellular therapies - Vivodyne accelerates the discovery of cures to hum ...
Turn Biotechnologies	Pharmaceuticals & Biotechnology	Fighting age-related disease at the cellular level - Turn Biotechnologies, Inc. is a Silicon Valley-bas ...

View more competitors»

Date	Round	Amount	Investors
Mar 28, 2007	Series D	$ 50,000,000	Skyline Ventures Pequot Capital D E Shaw Co Perseus Brookside Capital Bay City Capital
Jan 31, 2006	Series C	$ 25,249,000	Perseus Bay City Capital Skyline Ventures
Sep 07, 2004	Series B	$ 30,000,000	Skyline Ventures Pequot Capital Bay City Capital

Date	Acquired	Amount
There are no acquisitions.

Product	Stage	Description
There are no products.

Person	Role	Period
There are no team members.